Analysis of cell‐free circulating DNA fragment size and level in patients with lumbar canal stenosis
Abstract Cell‐free circulating DNA (cfDNA), extracted by liquid biopsy, has been studied as a noninvasive biomarker for various diseases. The potential of cfDNA fragment size and level as a marker in lumbar canal stenosis (LCS) patients has never been studied. We investigated whether cfDNA is a biom...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | JOR Spine |
Subjects: | |
Online Access: | https://doi.org/10.1002/jsp2.1189 |